Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8131-8140 Newer>

The Motley Fool December 15, 2011 Luke Timmerman	Vertex Names Jeff Leiden As New CEO, Staring Down Tough New Competition What does new leadership mean for Vertex's future?
The Motley Fool December 14, 2011 David Williamson	BioSante Investors: It Was Nice While It Lasted Libigel loses to placebo in two studies, shares down 75% after hours.
The Motley Fool December 14, 2011 Neha Chamaria	Can Pall Stand Tall After an Impressive Quarter? Emerging markets play a positive role.
The Motley Fool December 13, 2011 David Williamson	3 Biotechs Making Big Moves on Big News Trial results and FDA panels ruled the health-care sector today.
The Motley Fool December 13, 2011 Brian Orelli	Dividend? Buyback? Here's How to Get Both. But will there be enough to replenish the pipeline?
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
The Motley Fool December 13, 2011	A Brief History of Teva Pharmaceutical's Returns The good news is that, at 15 times earnings, Teva shares now look reasonably valued.
The Motley Fool December 13, 2011 Frank Vinluan	N.C. Novartis Site Is First Cell-Based Flu Vaccine Facility in the Country A Novartis' vaccine facility in North Carolina today became the first facility authorized by the FDA for emergency use during a pandemic.
The Motley Fool December 13, 2011 Dan Caplinger	Has Boston Scientific Become the Perfect Stock? Since we looked at Boston Scientific last year, the maker of medical devices has gotten up off the mat and quadrupled its score.
The Motley Fool December 12, 2011 Brian Orelli	FDA Irony: Less Data, Longer Review Poor Onyx Pharma.
<Older 8131-8140 Newer> Return to current articles.